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Clinical characteristics and management 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
 11.06.2020 Merits and 
culprits of 
immunotherapies 
for neurological 
diseases in times 
of COVID-19 
EBioMedicine 
| Review 
 An overview, of 
the most recently 
available data 
about SARS-CoV-
2 and the 
approved 
immunotherapies 
for neurological 
diseases, that 
includes current 
treatment 
strategies and the 
associated 
COVID-19 risk 
and the potential 
of 
immunotherapies 
to treat COVID-19 
 Immunotherapy, 
neurology 
  
05.06.2020 Rapid generation 
of neutralizing 
antibody 
responses in 
COVID-19 
patients  
Cell | Article 
 Cross-sectional 
study of antibody 
responses to the 
receptor binding 
domain (RBD) of 
the spike protein 
and neutralisation 
activity in a cohort 
of hospitalised 
Antibody 
response, 
protective 
immunity   
2 
COVID-19 
patients 
 A robust humoral 
immune response 
occurs early 
during severe or 
moderate C19 
infection 
 These kinetic 
findings support 
the effort in 
applying antibody 
testing for clinical 
diagnostic 
purposes and 
highlight the 
importance of 
timing of these 
tests  
 The appearance 
of high titer 
neutralising 
antibody 
responses early 
after infection 
suggests there 
may be some 
degree of 
protection from 
re-infection  
 Further studies 
will need to define 
the neutralising 
titer which 
correlates with 
protective 
immunity and 
determine the 
durability of the 
responses over 
time. 
08.06.2020 Pulmonary post-
mortem findings 
in a series of 
COVID-19 cases 
from northern 
Italy: a two-
centre 
descriptive study 
Lancet 
Infectious 
Diseases | 
Article 
 Analysed lung 
tissue samples 
from 38 patients 
who died from 
COVID-19 in two 
hospitals in 
northern Italy 
between Feb 29 
and March 24, 
2020 
 The predominant 
pattern of lung 
lesions in patients 
with COVID-19 
 
  
3 
patients is diffuse 
alveolar damage, 
as described in 
patients infected 
with severe acute 
respiratory 
syndrome and 
Middle East 
respiratory 
syndrome 
coronaviruses. 
Hyaline 
membrane 
formation and 
pneumocyte 
atypical 
hyperplasia are 
frequent. 
Importantly, the 
presence of 
platelet–fibrin 
thrombi in small 
arterial vessels is 
consistent with 
coagulopathy, 
which appears to 
be common in 
patients with 
COVID-19 and 
should be one of 
the main targets 
of therapy. 
  
04.06.2020 Maternal and 
neonatal 
outcomes 
associated with 
COVID-19 
infection: A 
systematic 
review 
PLOS One | 
Research 
article 
 With limited understanding of the 
effects of COVID-19 during 
pregnancy, clinicians and patients 
are forced to make uninformed 
decisions. 
 Conclusions - COVID-19-positive 
pregnant women present with 
fewer symptoms than the general 
population and may be RT-PCR 
negative despite having signs of 
viral pneumonia. The incidence of 
preterm births, low birth weight, C-
section, NICU admission appear 
higher than the general population. 
  
4 
Epidemiology and modelling  
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
12.06.2020 Predicted 
COVID-19 
fatality rates 
based on 
age, sex, 
comorbidities, 
and health 
system 
capacity 
CGD | 
Working 
Paper 
 Non-random testing and 
incomplete vital 
registration systems 
challenge estimating 
directly the infection 
fatality rate (IFR) in 
many LMICs 
 This paper estimates 
the adjustments 
required to extrapolate 
estimates of IFR from 
high- to lower-income 
regions 
 Predicted IFR across 21 
world regions range 
from 0.11% in Western 
sub-Saharan Africa to 
1.07% for high-income 
Asia Pacific when 
accounting for 
differences in the 
distribution of age, sex, 
and relevant 
comorbidities 
 Adjusting for health 
system capacity greatly 
diminishes, but does not 
erase entirely, the 
demography-based 
advantage predicted 
from the lowest income 
settings 
 Code for this paper is 
available 
Mortality, 
LMICs 
 12.06.2020 The 
effectiveness 
of social 
bubbles as 
part of a 
Covid-19 
lockdown exit 
strategy, a 
modelling 
study 
 medRxiv | 
Preprint (not 
peer 
reviewed) 
 The impact of contact 
clustering in social 
bubbles, as part of 
gradual lockdown exit 
strategy, on epidemic 
and mortality risk was 
estimated using the UK 
as a case study 
 Analysis highlights the 
continued need for 
social distancing despite 
a social bubble strategy 
being effective in 
expanding contacts 
Social 
bubbles, 
exit strategy 
5 
while limited the risk for 
a resurgence of cases.  
 Recommending social 
bubbles only for those 
struggling with lockdown 
alongside continuing 
prioritising outdoor 
settings for gathers and 
maintaining social 
distancing could strike a 
balance between 
minimising the impact 
on mental health and 
minimising the C19 
epidemic risk 
09.06.2020 Update Alert: 
Epidemiology 
of and risk 
factors for 
coronavirus 
infection in 
health care 
workers 
Annals of 
Internal 
Medicine | 
Letter 
 First monthly update 
alert for a living review 
on the epidemiology and 
risk factors for 
coronavirus infections in 
HCWs 
Risk factors, 
infection, 
HCWs 
09.06.2020 Sex 
differences in 
immune 
responses to 
SARS -CoV-2 
that underlie 
disease 
outcomes 
medRxiv | 
Preprint (not 
peer 
reviewed) 
  
 This study examined 
sex differences in viral 
loads, SARS-CoV-2-
specific antibody titres, 
plasma cytokines and 
blood cell phenotyping 
in C19 patients with mild 
to moderate disease 
who had not received 
immunomodulatory 
medications 
 Findings reveal a 
possible explanation 
underlying observed sex 
biases in C19  
Sex, 
immune 
responses 
09.06.2020 An analysis 
of SARS-
CoV-2 viral 
load by 
patient age 
medRxiv | 
Preprint (not 
peer 
reviewed) 
  
 Analysis to examine the 
relationship between 
patient age and 
estimated viral load from 
this study conducted in 
Germany concludes that 
a considerable 
percentage of infected 
people in all age groups, 
including those who are 
pre- or mild-
symptomatic, carry viral 
loads like to represent 
infectivity 
Age, viral 
load, 
infectivity 
6 
 Authors recommend 
caution and careful 
monitoring during 
gradual lifting of NPIs. 
There is little evidence 
from the present study 
to support suggestions 
that children may not be 
as infectious as adults 
08.06.2020 Reduction in 
mobility and 
COVID-19 
transmission 
ICL | Report 
26 
 Mobility data represent 
an important proxy of 
measure of social 
distancing 
 This modelling study 
developed a framework 
and applied to 53 
countries with sustained 
SARS-CoV-2 
transmission based on 
two distinct country-
specific automated 
measures of human 
mobility – Apple and 
Google. The relationship 
between mobility and 
transmission was 
consistent within and 
across countries 
 Enhanced control 
measures necessary to 
expect a decline in new 
infections (R<1) are still 
warranted for the 
majority of countries 
 Early evidence was 
found of some 
decoupling of 
transmission and 
mobility in 10 countries 
– a key indicator of 
successful easing of 
social-distancing 
restrictions 
Mobility, 
transmission 
 
 
 
7 
Infection Prevention and Control 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
12.06.2020 The impact of 
COVID-19 
and strategies 
for mitigation 
and 
suppression 
in low- and 
middle-
income 
countries 
Science | 
Research 
Article 
 Analysis combines data 
on demography, 
contact patterns, 
disease severity and 
health care capacity 
and quality to 
understand its impact 
and inform strategies 
for its control 
 Limited health system 
capacity and closer 
inter-generational 
contact negate the 
“benefit” of younger 
populations in LICs 
 Mitigation strategies 
that slow but do not 
interrupt transmission 
will still result in health 
systems being 
overwhelmed due to the 
poorer health care 
available 
 Many lower income 
countries acted quickly 
when transmission was 
low which likely 
substantially slowed 
viral spread 
 This will need to be 
maintained or triggered 
frequently to keep 
within health care 
capacity 
Mitigation, 
suppression, 
health care 
capacity 
  
04.06.2020 The natural 
history and 
transmission 
potential of 
asymptomatic 
SARS-CoV-2 
infection 
Clinical 
infectious 
diseases 
 A massive coronavirus 
testing campaign in 
Vietnam has found 
evidence that infected 
people who never show 
any symptoms can 
pass the virus to others. 
 Early in the global 
COVID-19 outbreak, 
Vietnam began to 
repeatedly test people 
at high risk of infection. 
Those who tested 
positive were admitted 
testing 
  
8 
to a hospital until they 
either recovered or 
tested negative. 
 Of roughly 14,000 
people tested between 
mid-March and early 
April, 49 were infected. 
Le Van Tan at the 
Oxford University 
Clinical Research Unit 
in Ho Chi Minh City, 
Vietnam, and his 
colleagues monitored 
30 of the 49 individuals 
and found that 13 
developed no 
symptoms during their 
hospital stay 
09.06.2020 Exploring the 
correlation 
between 
COVID-19 
fatalities and 
poor WASH 
services 
medRxiv | 
Preprint (not 
peer 
reviewed) 
  
 It is currently unknown 
whether poor or non-
availability of WASH 
services are closely 
related to C19 fatalities 
 Analysis of data on C19 
fatality rates in SSA 
with indicators of safe 
water and sanitation 
governance show a 
strong correlation 
between a higher case 
fatality rate and poorer 
access to safe drinking 
water as well as safe 
sanitation 
 Whilst an associated 
was confirmed by this 
study, this analysis 
does not establish 
causality 
Mortality, 
WASH 
  
08.06.2020 The effect of 
large-scale 
anti-contagion 
policies on 
the COVID-19 
pandemic 
Nature | 
Article 
 We estimate that early 
infections of COVID-19 
exhibit exponential 
growth rates of roughly 
38% per day. We find 
that anti-contagion 
policies have 
significantly and 
substantially slowed 
this growth. 
 These findings may 
help inform whether or 
when these policies 
should be deployed, 
intensified, or lifted, and 
they can support 
Masks, 
social 
contact 
  
9 
decision-making in the 
other 180+ countries 
where COVID-19 has 
been reported 
06.06.2020 The impact of 
COVID-19 
control 
measures on 
social 
contacts and 
transmission 
in Kenyan 
informal 
settlements 
medRxiv | 
Preprint (not 
peer 
reviewed) 
 Study collected contact 
data from residents of 
informal settlements 
around Nairobi, Kenya 
to assess if control 
measures have 
changed contact 
patterns, and estimate 
the impact of changes 
on the basic 
reproduction number 
(R0). 
 COVID-19 control 
measures have had a 
large impact on direct 
contacts and therefore 
transmission, but have 
also caused 
considerable economic 
and food insecurity. 
Reductions in R0 are 
consistent with the 
linear epidemic growth 
in Kenya and other sub-
Saharan African 
countries that 
implemented similar, 
early control measures 
Masks, 
social 
contact 
  
05.06.2020 SARS-CoV-2 
in 
environmental 
samples of 
quarantined 
households 
medRxiv | 
Preprint (not 
peer 
reviewed) 
 Contaminated surfaces 
might have only a minor 
role in transmitting 
COVID-19 within 
households. 
 Ricarda Schmithausen 
at the University of 
Bonn in Germany and 
her colleagues looked 
for traces of the virus 
SARS-CoV-2 in 21 
households that each 
included at least one 
infected person. The 
team found viral RNA in 
just 3% of samples from 
the most frequently 
touched objects, such 
as door knobs, and in 
15% of samples taken 
from bathroom drains 
and toilets. The team 
could not grow 
Surfaces 
  
10 
infectious virus from 
any of the samples. 
 All 15 samples from air 
monitors designed to 
pick up fine respiratory 
aerosol particles tested 
negative for viral RNA, 
although the authors 
say that the method 
they used means this 
result should be 
interpreted cautiously. 
 The findings suggest 
that direct transmission 
of the coronavirus, for 
example through 
exhaled or coughed 
droplets, is probably the 
main route of infection. 
However, transmission 
in wastewater is a 
possible route of 
infection, the authors 
add. 
Testing 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
  
11.06.2020 Systematic 
SARS-CoV-2 
screening in 
cerebrospinal 
fluid during 
the COVID-
19 pandemic 
The Lancet 
Microbe | 
Correspondence 
 Retrospective systematic 
screening of all 
cerebrospinal fluid (CSF) 
samples (n=622) at 
University Hospital in 
Lyon, France 1 Feb to 11 
May 2020 
 SARS-CoV-2 detection in 
CSF samples was very 
low suggesting that 
although SARS-CoV-2 
can replicate in neuronal 
cells in vitro, SARS-CoV-2 
testing in CSF is currently 
not relevant in the general 
population 
 Further studies are 
required to identify the 
potential role of the host-
immune response on 
neurological manifestation 
in patients with C19 
Testing, 
CSF  
  
11 
12.06.2020 Evaluation of 
sample 
pooling for 
screening of 
SARS-CoV-2 
medRxiv | 
Preprint (not 
peer reviewed) 
 This study recommends 
pooling of 4 in 1 using the 
standard protocols of the 
assay, reagents and 
equipment, expected to 
retain test accuracy 
 This approach allows 
expansion of screening 
capacity  
 Sample 
pooling 
  
12.06.2020 An imperfect 
tool: COVID-
19 ‘test & 
trace’ 
success 
relies on 
minimising 
the impact of 
false 
negatives 
and 
continuation 
of physical 
distancing 
 medRxiv | 
Preprint (not 
peer reviewed) 
 Although this study 
extends an existing UK-
focused branching 
process model, it 
highlights that test 
accuracy must be 
considered when relaxing 
physical distancing 
measures through contact 
tracing. 
Test 
accuracy 
  
 08.06.2020  Optimising 
SARS-CoV-2 
pooled 
testing for 
low-resource 
settings 
 Lancet Microbe 
| Comment 
 Several policy proposals 
support mass individual 
testing to suppress SARS-
CoV-2 but with restricted 
testing capacity, such 
testing is not only 
infeasible for low-income 
countries, but also an 
inefficient use of scarce 
testing kits that adversely 
affects the global supply 
of testing kits. 
 Group testing offers a 
viable alternative. 
 This article discusses 
three different approaches 
to group testing that are 
benchmarked against 
individual testing. 
  
  
  
12 
Therapeutics 
Publicatio
n date 
Title/URL Journal/Articl
e type 
Summary             Keywords 
11.06.2020 Hydroxychloroquin
e proves ineffective 
in hamsters and 
macaques infected 
with SARS-CoV-2 
bioRxiv | 
Preprint (not 
peer 
reviewed) 
 Although many human 
clinicals trials are 
ongoing assessing 
efficacy of 
prophylactic/therapeuti
c use of 
hydroxychloroquine 
(HCQ) for C19 there 
remains a lack of 
supportive preclinical 
drug efficacy studies 
 This preclinical animal 
study in two animal 
models does not 
support the use of 
HCQ in 
prophylaxis/treatment 
of C19 
 Preclinical
, HCQ 
Vaccines 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
10.06.2020 Generation of 
a Broadly 
Useful Model 
for COVID-19 
Pathogenesis 
Vaccination, 
and 
Treatment 
Cell | Article 
 It is critical that 
vaccines and 
therapeutics be 
developed very 
rapidly. Mice, the 
ideal animal for 
assessing such 
interventions, are 
resistant to SARS-
CoV-2. 
 Article describes a 
murine model of 
broad and 
immediate utility to 
investigate COVID-
19 pathogenesis, 
and to evaluate 
new therapies and 
vaccines. 
mouse model, 
pathogenesis, 
therapeutics, 
vaccine 
13 
  
10.06.2020 Neuropilin-1 
facilitates 
SARS-CoV-2 
cell entry and 
provides a 
possible 
pathway into 
the central 
nervous 
system 
bioRxiv | 
Preprint (not 
peer 
reviewed) 
  
 Researchers have 
found a second 
protein that SARS-
CoV-2 uses to 
enter human cells, 
potentially offering 
a new target for 
vaccines and 
drugs. 
 The SARS-CoV-2 
protein called 
Spike is known to 
attach to a human 
protein called 
ACE2, which 
allows the virus to 
enter cells. Two 
teams of 
researchers have 
now found that the 
human protein 
neuropilin-1 
(NRP1) also aids 
viral invasion. 
 Peter Cullen and 
Yohei Yamauchi at 
the University of 
Bristol, UK, and 
their colleagues 
showed that a 
fragment of the 
Spike protein can 
bind to NRP1 
vaccine 
05.06.2020 Neuropilin-1 
is a host 
factor for 
SARS-CoV-2 
infection 
bioRxiv | 
Preprint (not 
peer 
reviewed) 
 This team found 
that in mice, NRP1 
assists the entry of 
virus-sized 
particles into the 
central nervous 
system.  
 The two studies 
suggest that 
blocking the 
interaction 
between the virus 
and NRP1 could 
Vaccine 
14 
provide a way to 
combat 
coronavirus 
infection. 
 06.06.2020 Development 
of an 
inactivated 
vaccine 
candidate, 
BBIBP-CorV, 
with potent 
protection 
against 
SARS-CoV-2 
 Cell | Article 
 An inactivated 
SARS-coV-2 
vaccine candidate 
BBIP-CorV 
 This vaccine 
induces high levels 
of neutralising 
antibody titres in 
animal models 
 Two-does 
immunisation with 
2ug/dose of the 
vaccine candidate 
efficiently protects 
rhesus macaques 
 This vaccine 
candidate exhibits 
efficient 
productivity and 
good genetic 
stability for vaccine 
manufacture 
Vaccine 
candidate, 
animal models   
Social Science 
Publication 
date 
Title/URL Journal/Article 
type 
Summary Keywords 
05.06.2020 Mental Health 
Status of 
Medical Staff in 
Emergency 
Departments 
During the 
Coronavirus 
Disease 2019 
Epidemic in 
China 
Brain, 
behaviour and 
immunity 
 14,825 doctors and 
nurses in 31 provinces 
of mainland China 
completed the survey 
 Prevalence rates of 
depressive symptoms 
and post-traumatic 
stress disorder (PTSD) 
were 25.2% for doctors 
and 9.1% for nurses. 
Men were more likely to 
have depressive 
symptoms and PTSD 
than women.  
 Findings suggest 
targeted psychological 
interventions to promote 
Mental 
health, 
China 
15 
the mental health of 
medical staff with 
psychological problems 
need to be immediately 
implemented. Special 
attention should be paid 
to local medical staff in 
Hubei. 
08.06.2020 Quantify the 
role of 
superspreaders 
-opinion 
leaders- on 
COVID-19 
information 
propagation in 
the Chinese 
Sina-microblog 
PLOS One | 
article 
 Effective communication 
of accurate information 
through social media 
constitutes an important 
component of public 
health interventions 
 Study is a mathematical 
model to quantify the 
roles of information 
superspreaders in single 
specific information 
which outbreaks rapidly 
and usually has a short 
duration period, and to 
examine the information 
propagation dynamics in 
the Chinese Sina-
microblog. 
  
Comments, Editorials, Opinions, Blogs, News 
Publication 
date 
Title/URL Journal | 
Article type 
Author(s) 
  
13.06.2020 COVID-19 vaccines for all?  The Lancet | 
World Report 
Ann Danaiya 
Usher 
  
13.06.2020 Offline: COVID-19 - what can we expect to 
come 
The Lancet | 
Comment 
Richard Horton 
  
12.06.2020 Predicting COVID-19 infection fatality rates 
around the world 
CGD | Blog Justin Sandefur 
et al. 
  
11.06.2020 Socio-demographic and epidemiological 
consideration of Africa’s COVID-19 
response: what is the possible pandemic 
course? 
Nature 
Medicine | 
Comment 
Bamba Gaye et 
al. 
16 
09.06.2020 Update Alert: Epidemiology of and Risk 
Factors for Coronavirus Infection in Health 
Care Workers 
Annals of 
Internal 
Medicine | 
Letter 
Roger Chou, 
Tracy 
Dana,  David I. 
Buckley, Shelley 
Selph, 
09.06.2020 When the Dust Settles: Preventing a Mental 
Health Crisis in COVID-19 Clinicians 
Annals of 
Internal 
Medicine | 
Ideas and 
opinions 
Stephanie B. 
Kiser, Rachelle 
E. Bernacki, 
09.06.2020 The Impact of COVID-19 on Food Security 
and Nutrition             
UN | Policy 
Brief 
  
10.06.2020 The Importance of Proper Death 
Certification During the COVID-19 
Pandemic 
JAMA | 
Viewpoint 
James R. Gill, 
Maura E. 
DeJoseph, DO 
10.06.2020 Hydroxychloroquine side-effects raise 
concerns for rheumatology patients  
Lancet 
Rheumatology 
| News 
Brian Owens 
09.06.2020 Overcoming COVID-19: Addressing the 
perception of risk and transitioning 
protective behaviours to habits 
Infection 
control & 
hospital 
infection | 
Letter 
Mohamad G. 
Fakih 
Lisa Sturm 
Rand R. Fakih 
09.06.2020 Evaluation of modelling study shows limits of 
COVID-19 importing risk simulations in sub-
Saharan Africa 
Epidemiology 
& Infection  
T Miyachi 
T Tanimoto 
M Kami 
09.06.2020 Addressing the public mental health 
challenge of COVID-19 
The Lancet | 
Psychiatry 
Jonathan 
Campion 
Afzal Javed 
Norma Sartorius 
Michael Marmot 
17 
06.06.2020 Letter to the Editor regarding “COVID-19 
and Neurosurgical Education in Africa”; How 
the pandemic is changing neurosurgical 
education in Morocco. 
World 
Neurosurgery 
| Letter to 
editor 
Mohammed 
Yassaad Oudrhiri 
et al  
08.06.2020 COVID-19 and measles: double trouble for 
Burundi 
Lancet 
Microbe | 
News 
Sanjeet Bagcchi 
01.06.2020 COVID-19 diagnostics—not at the expense 
of other diseases 
Lancet 
Microbe | 
News 
Priya Venkatesan 
01.06.2020 We risk letting a new threat expose us to old 
enemies 
Lancet 
Microbe 
  
08.06.2020 Global health under fire: Trump and covid 
are just two of the threats 
BMJ | Feature Mara Kardas-
Nelson 
07.06.2020 Nigeria: Coronavirus - Abia Cases 
Quadruple As Nigeria Records 260 New 
Infections 
All Africa   
06.06.2020 COVID-19 vaccine development pipeline 
gears up 
Lancet | 
World Report 
Asher Mullard 
05.06.2020 The WHO we want Lancet | 
Comment 
Olivier 
Nay,  Marie-
Paule Kieny, 
Lelio Marmora, 
Michel 
Kazatchkine 
05.06.2020 False Negative Tests for SARS-CoV-2 
Infection — Challenges and Implications 
NEJM | 
Perspectives 
Steven 
Woloshin,  Neeraj 
Patel, and Aaron 
S. Kesselheim,  
05.06.2020 Caring for Women Who Are Planning a 
Pregnancy, Pregnant, or Postpartum During 
the COVID-19 Pandemic 
JAMA 
Insights 
Sonja A. 
Rasmussen, 
Denise J. 
Jamieson 
18 
04.06.2020 Kenya: Govt to Roll Out Home-Based Care 
for COVID-19 Patients, Kagwe Says 
All Africa    
04.06.2020 Kenya: Fistula Patients Suffer in Silence 
Amid COVID-19 
All Africa   
05.06.2020 An urgent call to address the nutritional 
status of women and children in Nepal 
during COVID-19 crises 
International 
journal for 
equity in 
health | 
Commentary 
  
08.06.2020 India coronavirus: Patients stranded as 
Delhi struggles with Covid 
BBC   
06.06.2020 Infections are rising fast in Bangladesh, 
India and Pakistan 
Economist   
07.06.2020 S.Africa government, private hospitals agree 
deal on COVID-19 patients 
Reuters   
Guidelines, Statements & Tools 
Publication 
Date 
Title/URL Source   Summary 
 10.06.2020 COVID-19 
measures must be 
grounded first and 
foremost on the 
right to health 
OHCHR | 
Press 
release 
 UN Human Rights Special 
Rapporteur press release on the 
right to health foundation of the 
C19 response 
  
19 
Dashboards & Trackers 
Cases & 
deaths: 
Global 
Cases & 
deaths: 
Regional 
Cases & 
deaths: 
Country 
Living 
evidence & 
policy maps 
Current 
research 
including trials 
  Diagnostics  Treatments   Vaccines 
WHO sitreps WHO 
Africa 
Ghana COVID-
NMA 
WHO   FIND 
SARS-CoV-
2 Test 
Tracker 
  Global 
COVID-19 
Clinical Trial 
Tracker 
  CEPI 
WHO 
dashboard 
African 
Arguments 
Indonesia EPPI 
Centre 
WHO 
International 
Clinical Trials 
Registry 
Platform 
(ICTRP) 
 FIND 
SARS-CoV-
2 
Diagnostics: 
performance 
data 
  US NIH 
registered 
clinical trials 
Vaccine 
Centre 
LSHTM 
Johns 
Hopkins 
University 
European 
CDC 
Nigeria 
CDC 
Norwegian 
Institute of 
Public 
Health 
Cytel  Serology-
based tests 
for COVID-
19 
  Solidarity 
trial 
 COVID-
19 Oxford 
Vaccine 
Trial 
WEF 
  Sierra 
Leone 
 Oxford C19 
Government 
Response 
Tracker 
(OxCGRT) 
US NIH  Our World 
in Data: C19 
Testing 
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Online learning & events 
Date Title/URL Online 
learning/event 
Duration Lead 
Available 
now 
Standard precautions: 
Environmental 
cleaning and 
disinfection 
Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 
Virtual event 1h 30 
hours 
ODI 
15.06.2020 Poverty monitoring in 
the context of Covid-
19 
Virtual event 1h 15 ODI 
Available 
now 
COVID-19: Effective 
Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 
Johns Hopkins School 
of Nursing 
          
Available 
now 
WHO Academy and 
WHO Info mobile 
applications 
Mobile app   WHO 
Available 
now 
COVID-19: 
Pandemics, Modelling 
and Policy 
Online 
learning 
2 weeks | 2 
hours 
weekly 
study 
FutureLearn UNESCO 
UNITWIN Complex 
Systems Digital 
Campus/Open 
University 
12.05.2020 COVID-19 and 
maintaining quality 
essential health 
services  
Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 
11.5.2020 COVID-19 Contact 
Tracing course 
Online 
learning 
5 hours Johns Hopkins 
Bloomberg School of 
Health 
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7-28 May 
2020 
Virtual Evidence 
Weeks 
5 sessions 1h 30 International Initiative 
for Impact Evaluation 
(3ie) 
Tuesdays at 
1700 CEST 
(Geneva 
time) & 
Thursdays 
0830 CEST 
(Geneva 
time) 
COVID-19 Open 
online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
Event 1h 20 Gresham College 
Available 
now 
Emerging respiratory 
viruses, including 
COVID-19: methods 
for detection, 
prevention, response 
and control 
Online 
learning 
3 hours WHO 
Available 
now 
Responding to 
COVID-19: Real-time 
training for the 
coronavirus disease 
outbreak 
Online 
learning 
Multiple 
self-paced 
course 
WHO 
25 May 
2020 
COVID-19: Tackling 
the Novel Coronavirus 
Online 
learning 
3 weeks | 4 
hours 
weekly 
study 
FutureLearn 
LSHTM/UK PHRST 
Available 
online now 
without 
mentors. 
Updated 
version will 
commence 
early June 
2020 
COVID-19 
Diagnostics and 
Testing 
Online 
learning 
3 weeks | 3 
hours 
weekly 
study 
FutureLearn 
FIND/LSHTM/ASLM 
25 
6 April 2020 COVID-19 Critical 
Care: Understanding 
and Application 
Online 
learning 
5 weeks | 1 
hour 
weekly 
study 
FutureLearn University 
of Edinburgh & Royal 
College of Physicians 
of Edinburgh  
Available 
now 
COVID-19 supporting 
online courses 
Online 
learning 
Multiple 
self-paced 
course 
BMJ Learning 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa” OR “South Asia” OR “Developing” OR “low-income” OR “low 
income” OR “lower-middle income” OR “low and middle income” OR “LMIC” OR “LIC” OR “global south”) OR 
(“poverty”) OR (“equity” OR “equities”), restricted to articles published in the previous 2 to 3 days, in English. This 
is complemented by a search of the homepage of the following high-impact global health journals: The Lancet 
journals, New England Journal of Medicine, Nature, JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ 
Global Health, the PLoS journals and a Twitter search of their Twitter pages. A search also of preprints from bioRxiv 
and medRxiv. Please note that papers that have not been peer-reviewed are highlighted in red. All primary 
research papers that relate to the primary and secondary impacts of the COVID-19 response in LMICs, and disease 
control and health system responses are included. Articles related to tackling the secondary impacts on other 
sectors are not included. Additional commentaries, opinions, and commissioned pieces are selected based on 
relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
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About this report 
This is a weekly summary of the daily COVID-19 health evidence summary (HES) which are based on 3 hours of 
desk-based research each day. The summary is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to decision 
makers which, if relevant to them, they should go to before making decisions. The HES are not intended to replace 
medical or professional advice and the researcher or the K4D consortium cannot be held responsible for any 
decisions made about COVID-19 on the basis of the HES alone. K4D services are provided by a consortium of 
leading organisations working in international development, led by the Institute of Development Studies (IDS), with 
Education Development Trust, Itad, University of Leeds Nuffield Centre for International Health and Development, 
Liverpool School of Tropical Medicine (LSTM), University of Birmingham International Development Department 
(IDD) and the University of Manchester Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for International 
Development (DFID) and its partners in support of pro-poor programmes. It is licensed for 
non-commercial purposes only. K4D cannot be held responsible for errors, omissions or any 
consequences arising from the use of information contained in this health evidence summary. 
Any views and opinions expressed do not necessarily reflect those of DFID, K4D or any other 
contributing organisation.   
© DFID - Crown copyright 2020. 
